You Just Have To Wait: FDA Can't Hurry PDUFA VI Guidances

In response to stakeholder concern about multi-year schedule for patient-input guidance development, FDA says it only has a few experts and has to balance their time.

PDUFA VI letter

More from Clinical Trials

More from R&D